Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sugar Found in Red Meat Causes Chronic Inflammation in Human-Like Mouse Model

By LabMedica International staff writers
Posted on 06 Jan 2015
Chronic inflammation in humans, which has been linked to tumor formation as well as development of other syndromes such as atherosclerosis and type II diabetes, may be a response to red meat in the diet that contains the sugar N-Glycolylneuraminic acid (Neu5Gc).

Humans differ from other mammals by being unable to synthesize Neu5Gc, as the human CMAH gene has been irreversibly mutated and produces an inactive form of the enzyme CMP-N-acetylneuraminic acid hydroxylase, which is the enzyme responsible for synthesizing CMP-Neu5Gc from CMP-N-acetylneuraminic (CMP-Neu5Ac) acid. More...
Even though Neu5Gc cannot be produced by humans, it has been found in human cancers and fetal samples, which suggests that molecules of Neu5Gc enter human pathways through external sources, such as diet. Some researchers have suggested that eating red meat could lead to inflammation if the body’s immune system constantly generates antibodies against consumed animal Neu5Gc, a foreign molecule.

To study the relationship between red meat consumption and tumor development, investigators at the University of California, San Diego (USA) genetically engineered a mouse model to mimic the human condition by lacking Neu5Gc.

The investigators first evaluated the Neu5Gc content of various foods and showed that red meats were particularly rich in orally bioavailable Neu5Gc. They then fed this form of Neu5Gc to the human-like Neu5Gc-deficient mice. Results published in the December 29, 2014, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) revealed that when such mice were challenged with anti-Neu5Gc antibodies, they developed evidence of systemic inflammation. Long-term exposure to this combination resulted in a significantly higher incidence of carcinomas (five-fold increase) and an association with Neu5Gc accumulation in the tumors.

“Until now, all of our evidence linking Neu5Gc to cancer was circumstantial or indirectly predicted from somewhat artificial experimental setups,” said senior investigator Dr. Ajit Varki, professor of medicine and cellular and molecular medicine at the University of California, San Diego. “This is the first time we have directly shown that mimicking the exact situation in humans — feeding non-human Neu5Gc and inducing anti-Neu5Gc antibodies — increases spontaneous cancers in mice.”

“The final proof in humans will be much harder to come by,” said Dr. Varki. “But on a more general note, this work may also help explain potential connections of red meat consumption to other diseases exacerbated by chronic inflammation, such as atherosclerosis and type II diabetes. Of course, moderate amounts of red meat can be a source of good nutrition for young people. We hope that our work will eventually lead the way to practical solutions for this catch-22.”

Related Links:

University of California, San Diego



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.